Trade SRZN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Surrozen, Inc. (SRZN) is trading at US$23.44, down 6.50% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$281.97M. Over the past 52 weeks, SRZN has traded between US$11.39 and US$37.83. On Syfe you can trade SRZN with $0 commission and add it to your watchlist.
| Previous close | US$25.07 |
|---|---|
| Market cap | US$281.97M |
| 52-week range | US$11.39 – US$37.83 |
| Volume | 264.74K |
| Exchange | US |
Surrozen, Inc.
Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.
Year: 2021
Surrozen Files Investigational New Drug Application for SZN-8141 in Diabetic Macular Edema
Sep 8, 2:40 PM · MT Newswires
William Blair Initiates Surrozen at Outperform
Aug 20, 10:54 AM · MT Newswires
TD Cowen Initiates Surrozen at Buy
Apr 21, 11:26 AM · MT Newswires
Surrozen, Inc. (SRZN) stock is trading at US$23.44, -6.50% from the previous close of US$25.07.
The market cap for Surrozen, Inc. (SRZN) stock is approximately US$281.97M.
The 52-week high for Surrozen, Inc. (SRZN) stock is US$37.83.
The 52-week low for Surrozen, Inc. (SRZN) stock is US$11.39.
Surrozen, Inc. (SRZN) does not currently pay a dividend.
Stay on top of SRZN
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
